Clinical Trials Logo

Filter by:
NCT ID: NCT00501501 Completed - Hospitalization Clinical Trials

The Association Between Delivery Method and Maternal Rehospitalization

Start date: January 1999
Phase: N/A
Study type: Observational

Hypothesis: The rates of rehospitalization after cesarean section are significantly higher than those following spontaneous vaginal delivery and are due mainly to late bleeding and less to infection.

NCT ID: NCT00501033 Completed - Induction of Labor Clinical Trials

A Prospective Comparative Study of Induction of Labor With a Cervical Ripening Double Balloon vs Foley Catheter

Start date: January 2006
Phase: N/A
Study type: Interventional

Hypothesis: The induction of labor in patients with unfavorable Bishop score is a challenging obstetrical process, and may be influenced or complicated by the cervical ripening method used. We will conduct a comparative study of the foley catheter vs the cervical ripening double balloon (Cook medical, GPN: G48149). We will compare the failure rates, cesarean section rate, infections and postpartum complications, especially endometritis.

NCT ID: NCT00500019 Completed - Endometritis Clinical Trials

Uterine Flora During Elective and Urgent Cesarean Sections

Start date: January 2005
Phase: N/A
Study type: Observational

Hypothesis: The bacterial flora of the uterus during elective Cesarean sections differs from the uterine flora during non-elective Cesarean sections. We want to study whether the uterine flora can predict post-cesarean febrile morbidity and endometritis.

NCT ID: NCT00499837 Completed - Cystic Fibrosis Clinical Trials

Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients

Start date: September 2007
Phase: Phase 2
Study type: Interventional

Cystic Fibrosis (CF) is an inherited disorder in which mucus-secreting glands in the lungs produce considerable quantity of thick, sticky secretions that clog the airways, promote bacterial growth and lead to chronic obstruction, inflammation and destruction of the airways. The purpose of this study is to collect data about the resolution of the chronic inflammatory state in addition to assure the safety of the therapy in CF patients.

NCT ID: NCT00498888 Completed - Clinical trials for Urge Urinary Incontinence

The Long Term Outcomes of Rehabilitation and Drug Treatment for in Urgency Urinary Incontinence

UUI
Start date: June 2007
Phase: N/A
Study type: Interventional

- Urinary Urge Incontinence (UUI) is the involuntary urine loss associated with a strong sensation to void. - UUI usually associated with reduced bladder capacity. - The pathophysiology is unclear. - Pelvic floor muscle dysfunction and detrusor instability have been suggested as possible mechanisms. - Standard treatment includes anticholinergic medication and behavior modification. - The study aims to compare the long term effectiveness of 4 different approaches to the treatment of women with Urge Urinary Incontinence (UUI): 1. Pelvic Floor Rehabilitation (includes muscle training+behavioral intervention+bladder training) 2. Pelvic Floor muscle training alone 3. Bladder Training alone 4. Drug treatment with Tolterodine. - Study variables will include: impairment ratings, quality of life, and cost-effectiveness. - This study addresses three issues: 1. The long term efficacy and cost-effectiveness of the various treatment options. 2. To identify the factors involved in determining the effectiveness of drug or behavioral therapy. 3. The pathophysiology of UUI. By subdividing the rehabilitation group into 3 arms, we hope to shed light on the mechanism of dysfunction. A better response in one group will help localize the problem to pelvic floor muscles or to detrusor instability.

NCT ID: NCT00498680 Recruiting - Impotence Clinical Trials

Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i

Start date: March 2007
Phase: Phase 4
Study type: Interventional

A prospective, randomized, 3-arm parallel trial on 45 males with ED that were never exposed to PDE5i therapy (naïve patients) will be enrolled.In each group, every patient will receive three treatment regimes (Viagra®50mg & Levitra®10mg, Viagra®100mg, Levitra®20mg), in different sequences of administration in such a manner that eventually each patient will receive all regimes in a double- blinded fasion.Safety will be evaluated at pre- screening by measuring hourly vital signs (blood pressure, heart rate)for 4 consecutive hours after taking half-dose combination. Any decrease in blood pressure of 20 mmhg below baseline will exclude the subject from the study. Effcacy will be evaluated by questionnaires (IIEF, Quality of erection questionnaire, grade of erection scale, Sear, QVS and Sexual Encounter Profiles for each sexual event). Non-parametric statistical analysis of the collected data Comparing the 3 groups will be performed.

NCT ID: NCT00498667 Withdrawn - Clinical trials for Lymphoma; Large Cell (Diffuse) With Small Cell, Diffuse

The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma

Start date: December 2006
Phase: N/A
Study type: Observational

A retrospective analysis will be performed regarding the usefulness of PET/CT performed following 2 cycle of chemotherapy in evaluation of progression, free survival and overall survival of patients with aggressive non Hodgkin Lymphoma.

NCT ID: NCT00498589 Completed - Ulcerative Colitis Clinical Trials

Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis

METEOR
Start date: September 2007
Phase: Phase 2
Study type: Interventional

- PHASE: II - TYPE OF STUDY : With direct benefit - DESCRIPTIVE: Multicenter, randomized, double-blind study - INCLUSION CRITERIA: Steroid-dependent ulcerative colitis - OBJECTIVES: To show superiority of methotrexate vs placebo in inducing steroid-free remission in steroid-dependent ulcerative colitis - STUDY TREATMENTS: Methotrexate 1 intramuscular injection (25 mg) per week Placebo 1 intramuscular injection per week - NUMBERS OF PATIENTS: 55 patients in each group, i.e. a total of 110 patients - INCLUSION PERIOD: 24 months - STUDY DURATION: 36 months - EVALUATION CRITERIA: Remission without steroids, immunosuppressives and without colectomy at 16 weeks of treatment.

NCT ID: NCT00498576 Completed - Hypertension Clinical Trials

Melatonin and Adiponectin in Hypertensive Kidney Transplant

Start date: September 2007
Phase: N/A
Study type: Observational

Recently we have shown that melatonin secretion is impaired in rats with metabolic syndrome. We have also demonstrated that exogenic melatonin supplementation can improve blood pressure profile in nondipper patients. The aim of this study is to find whether there is a difference between melatonin secretion in hypertensive kidney recipients versus "normal" hypertensive patients. Secondly, to ask if there is any correlation between melatonin secretion and adiponectin levels.

NCT ID: NCT00498511 Not yet recruiting - Clinical trials for Anemia, Iron-Deficiency

Gastrointestinal Evaluation in Young Men With Iron Deficiency Anemia

Start date: August 2007
Phase: N/A
Study type: Observational

Both upper gastrointestinal endoscopy and colonoscopy are recommended in men and post-menopausal women with iron deficiency anemia. Due to lack of data on the yield of these endoscopies in young men, they are currently investigated as older men. The aim of this study is to evaluate prospectively the prevalence of various gastrointestinal lesions in young men with iron deficiency anemia. Our hypothesis is that the diagnostic yield of colonoscopy in young anemic men without gastrointestinal symptoms is very low, especially if a potential lesion is detected during upper gastrointestinal endoscopy. Therefore, this study will try to identify predicting factors regarding the yield of both endoscopies. Another purpose is to evaluate the outcome of patients with negative endoscopic results, during a follow-up of two years.